FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2616503145> ?p ?o ?g. }

• W2616503145 endingPage "e1328335" @default.
• W2616503145 startingPage "e1328335" @default.
• W2616503145 abstract "Our previous phase I/IIA study showed that autologous dendritic cells (DCs) pulsed with tumor-associated antigens are well tolerated in patients with hepatocellular carcinoma (HCC). In this randomized, multicenter, open-label, phase II trial, we investigated the efficacy and safety of this DC-based adjuvant immunotherapy with 156 patients, who treated for HCC with no evidence of residual tumor after standard treatment modalities. Patients were randomly assigned to immunotherapy (n = 77; injection of 3 × 107 DC cells, six times over 14 weeks) or control (n = 79; no treatment). The primary end point was recurrence-free survival (RFS), and the secondary endpoints were immune response and safety. The RFS between the immunotherapy and control groups was not significantly different (hazard ratio [HR], 0.97; 95% confidence interval [CI], 0.60–1.56; p = 0.90). However, post-hoc subgroup analyses revealed that DC immunotherapy significantly reduced the risk of tumor recurrence of non-radiofrequency ablation (non-RFA) group patients (n = 83, HR, 0.49; 95% CI, 0.26–0.94; p = 0.03), whereas unexpectedly increased the risk of recurrence in RFA group (n = 61, p = 0.01). Tumor-specific immune responses were significantly enhanced (both p < 0.01) in the immunotherapy group. Baseline serum interleukin (IL)-15 was statistically correlated with RFS prolongation (HR, 0.16; 95% CI, 0.03–1.58; p = 0.001) within the immunotherapy groups. Overall adverse events were more frequent in the immunotherapy group (p < 0.001) but were mainly mild to moderate in severity. In conclusion, adjuvant immunotherapy with DC vaccine reduces the risk of tumor recurrence in HCC patients who underwent standard treatment modalities other than RFA. Baseline IL-15 might be a candidate biomarker for DC-based HCC immunotherapy." @default.
• W2616503145 created "2017-05-26" @default.
• W2616503145 creator A5012779251 @default.
• W2616503145 creator A5022685072 @default.
• W2616503145 creator A5026334171 @default.
• W2616503145 creator A5035576878 @default.
• W2616503145 creator A5037098078 @default.
• W2616503145 creator A5044634922 @default.
• W2616503145 creator A5046190075 @default.
• W2616503145 creator A5053765314 @default.
• W2616503145 creator A5057552643 @default.
• W2616503145 creator A5065268090 @default.
• W2616503145 creator A5069465235 @default.
• W2616503145 creator A5077171293 @default.
• W2616503145 creator A5089681505 @default.
• W2616503145 date "2017-05-16" @default.
• W2616503145 modified "2023-10-14" @default.
• W2616503145 title "Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study" @default.
• W2616503145 cites W1493650729 @default.
• W2616503145 cites W1661544713 @default.
• W2616503145 cites W1911271782 @default.
• W2616503145 cites W1956923614 @default.
• W2616503145 cites W1966046743 @default.
• W2616503145 cites W1977949161 @default.
• W2616503145 cites W1988607812 @default.
• W2616503145 cites W1990459651 @default.
• W2616503145 cites W2008071876 @default.
• W2616503145 cites W2015054461 @default.
• W2616503145 cites W2032054834 @default.
• W2616503145 cites W2035799558 @default.
• W2616503145 cites W2039863327 @default.
• W2616503145 cites W2053760636 @default.
• W2616503145 cites W2058271074 @default.
• W2616503145 cites W2062162459 @default.
• W2616503145 cites W2066964346 @default.
• W2616503145 cites W2067101457 @default.
• W2616503145 cites W2084112669 @default.
• W2616503145 cites W2089187782 @default.
• W2616503145 cites W210616668 @default.
• W2616503145 cites W2106787323 @default.
• W2616503145 cites W2111616718 @default.
• W2616503145 cites W2111644861 @default.
• W2616503145 cites W2120072658 @default.
• W2616503145 cites W2120590606 @default.
• W2616503145 cites W2122179332 @default.
• W2616503145 cites W2122222213 @default.
• W2616503145 cites W2138494474 @default.
• W2616503145 cites W2147771351 @default.
• W2616503145 cites W2153935627 @default.
• W2616503145 cites W2155592152 @default.
• W2616503145 cites W2163403599 @default.
• W2616503145 cites W2163945848 @default.
• W2616503145 cites W2182743085 @default.
• W2616503145 cites W2219230917 @default.
• W2616503145 cites W2252702481 @default.
• W2616503145 cites W2261691410 @default.
• W2616503145 cites W2294927533 @default.
• W2616503145 cites W2345624579 @default.
• W2616503145 cites W2398211676 @default.
• W2616503145 cites W4211121538 @default.
• W2616503145 cites W4245784696 @default.
• W2616503145 doi "https://doi.org/10.1080/2162402x.2017.1328335" @default.
• W2616503145 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5543846" @default.
• W2616503145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28811965" @default.
• W2616503145 hasPublicationYear "2017" @default.
• W2616503145 type Work @default.
• W2616503145 sameAs 2616503145 @default.
• W2616503145 citedByCount "35" @default.
• W2616503145 countsByYear W26165031452017 @default.
• W2616503145 countsByYear W26165031452018 @default.
• W2616503145 countsByYear W26165031452019 @default.
• W2616503145 countsByYear W26165031452020 @default.
• W2616503145 countsByYear W26165031452021 @default.
• W2616503145 countsByYear W26165031452022 @default.
• W2616503145 countsByYear W26165031452023 @default.
• W2616503145 crossrefType "journal-article" @default.
• W2616503145 hasAuthorship W2616503145A5012779251 @default.
• W2616503145 hasAuthorship W2616503145A5022685072 @default.
• W2616503145 hasAuthorship W2616503145A5026334171 @default.
• W2616503145 hasAuthorship W2616503145A5035576878 @default.
• W2616503145 hasAuthorship W2616503145A5037098078 @default.
• W2616503145 hasAuthorship W2616503145A5044634922 @default.
• W2616503145 hasAuthorship W2616503145A5046190075 @default.
• W2616503145 hasAuthorship W2616503145A5053765314 @default.
• W2616503145 hasAuthorship W2616503145A5057552643 @default.
• W2616503145 hasAuthorship W2616503145A5065268090 @default.
• W2616503145 hasAuthorship W2616503145A5069465235 @default.
• W2616503145 hasAuthorship W2616503145A5077171293 @default.
• W2616503145 hasAuthorship W2616503145A5089681505 @default.
• W2616503145 hasBestOaLocation W26165031451 @default.
• W2616503145 hasConcept C121608353 @default.
• W2616503145 hasConcept C126322002 @default.
• W2616503145 hasConcept C143998085 @default.
• W2616503145 hasConcept C168563851 @default.
• W2616503145 hasConcept C203092338 @default.
• W2616503145 hasConcept C207103383 @default.
• W2616503145 hasConcept C2777701055 @default.
• W2616503145 hasConcept C2777863537 @default.

• next